Lance R McMahon
Overview
Explore the profile of Lance R McMahon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
1312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zequeira S, Gazarov E, Guvenli A, Berthold E, Senetra A, Febo M, et al.
Psychopharmacology (Berl)
. 2025 Feb;
242(4):835-853.
PMID: 39918581
Rationale: With increasing legalization of recreational and medical cannabis, use of this drug is growing rapidly among older adults. As cannabis can impair cognition in young adults, it is critically...
2.
Obeng S, McMahon L, Ofori E
Expert Opin Ther Pat
. 2025 Jan;
35(2):165-180.
PMID: 39816001
Introduction: Opioids have served as a cornerstone in pain management for decades. However, the emergence of increasingly potent synthetic analogs brings forth a range of side effects, including respiratory depression,...
3.
Obeng S, McMahon L, Ofori E
ACS Chem Neurosci
. 2024 Nov;
15(24):4360-4368.
PMID: 39606860
Drug overdose deaths in 2023 in the United States exceeded 107,000, with 80,000 of these deaths attributed to opioids alone. The emergence of synthetic opioids such as fentanyl and its...
4.
Zequeira S, Gazarov E, Guvenli A, Berthold E, Senetra A, Febo M, et al.
bioRxiv
. 2024 Nov;
PMID: 39574655
With increased legalization of recreational and medical cannabis, use of this drug is growing rapidly among older adults. As cannabis use can impair cognition in young adults, it is critically...
5.
Zuarth Gonzalez J, Mottinelli M, McCurdy C, de Lartigue G, McMahon L, Wilkerson J
Am J Physiol Regul Integr Comp Physiol
. 2024 Sep;
327(6):R568-R579.
PMID: 39250542
Kratom (), containing the primary alkaloid mitragynine, has emerged as an alternative self-treatment for opioid use disorder. Mitragynine binds numerous receptor types, including opioid receptors, which are known to modulate...
6.
Ortiz Y, Shamir L, McMahon L, Wilkerson J
PLoS One
. 2024 Aug;
19(8):e0309398.
PMID: 39208033
For many cancer patients tumor burden negatively impacts quality of life due to associated pain onset. Neuropathic pain is commonly associated with late cancer stages, and is resultant of tumor...
7.
Obeng S, Crowley M, Mottinelli M, Leon F, Zuarth Gonzalez J, Chen Y, et al.
Eur J Pharmacol
. 2024 Jul;
980:176863.
PMID: 39068978
Mitragynine, an alkaloid present in the leaves of Mitragyna speciosa (kratom), has a complex pharmacology that includes low efficacy agonism at μ-opioid receptors (MORs). This study examined the activity of...
8.
Shahbazi Nia S, Ortiz Y, Zuarth Gonzalez J, Shamir L, Frimpong-Manson K, Hossain M, et al.
ACS Pharmacol Transl Sci
. 2024 Mar;
7(3):654-666.
PMID: 38481688
Opioids represent the most extensive category of abused substances in the United States, and the number of fatalities caused by these drugs exceeds those associated with all other drug overdoses...
9.
Frimpong-Manson K, Ortiz Y, McMahon L, Wilkerson J
Front Mol Neurosci
. 2024 Mar;
17:1355281.
PMID: 38481473
The individual and global burden of migraine is of such significance that there are accelerated efforts to develop new therapies. New migraine therapeutics are needed to address the current deficiencies...
10.
Denison T, Sorensen K, Blanton M, Johnson L, Byrd T, Pass S, et al.
Qual Manag Health Care
. 2024 Feb;
33(4):269-277.
PMID: 38414295
This article describes the development of an institutional quality improvement review board (QIRB) as an effective and efficient method for reviewing and overseeing institutional quality improvement (QI) initiatives. QI projects...